Ion exchange purification of mrna
US-2016024141-A1 · Jan 28, 2016 · US
US11767548B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11767548-B2 |
| Application number | US-202117350662-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 17, 2021 |
| Priority date | Aug 18, 2017 |
| Publication date | Sep 26, 2023 |
| Grant date | Sep 26, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure provides, in some aspects, variant RNA polymerases, the use of which increases transcription efficiency while reducing the number of double-stranded RNA contaminates and run-on transcripts produced during an in vitro transcription reaction.
Opening claim text (preview).
What is claimed is: 1. A T7 ribonucleic acid (RNA) polymerase variant comprising an amino acid sequence having at least 95% identity to the amino acid sequence of SEQ ID NO: 1 modified to comprise an amino acid substitution at position S43, wherein the T7 RNA polymerase variant has RNA polymerase activity. 2. A composition or kit comprising the RNA polymerase variant of claim 1 and optionally an in vitro transcription (IVT) reagent. 3. The T7 RNA polymerase variant of claim 1 , wherein the amino acid substitution at position S43 is selected from the group consisting of alanine, isoleucine, leucine, methionine, lysine, glutamine, glutamate, and arginine. 4. The T7 RNA polymerase variant of claim 3 , wherein the amino acid substitution at position S43 is alanine (S43A). 5. The T7 RNA polymerase variant of claim 1 , wherein the T7 RNA polymerase variant comprises an amino acid sequence having at least 98% identity to SEQ ID NO:1. 6. The T7 RNA polymerase variant of claim 1 , wherein the RNA polymerase variant comprises the amino acid sequence of SEQ ID NO: 2. 7. A T7 ribonucleic acid (RNA) polymerase variant comprising an amino acid sequence having at least 95% identity to the amino acid sequence of SEQ ID NO: 1 modified to comprise an alanine at position 43, wherein the T7 RNA polymerase variant has RNA polymerase activity. 8. The T7 RNA polymerase variant of claim 7 comprising the amino acid sequence of SEQ ID NO: 2.
Polynucleotides, e.g. nucleic acids, oligoribonucleotides · CPC title
DNA-directed RNA polymerase (2.7.7.6) · CPC title
[RNA-polymerase-subunit] kinase (2.7.11.23) · CPC title
DNA-directed RNA polymerase (2.7.7.6) · CPC title
Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.